View and search all of our conferences.

Innovating a New Era of CNS Therapeutics

CNS (1)

World CNS Series Sponsorship Prospectus

 

Following a year of significant pharma acquisitions, first-in-class approvals, and a surge of financial backing to bolster innovation in new targets and preclinical pipelines, more companies are prioritizing neuroscience drug development than ever before. Our range of industry-dedicated conferences are designed to cover the full scope of CNS drug development and connect leading minds from CNS-focused pharma and biotech.

Download a copy

Testimonials

“An engaging and interactive conference, providing an opportunity for R&D leaders in neuropsychiatry to roll up their sleeves and discuss issues that we are collectively facing in this rapidly evolving field”

Chief Medical Officer, Delix Therapeutics

“Alzheimer’s & Parkinson’s Drug Development Summit is a great venue to develop meaningful collaborations in a pre-competitive environment to narrow the unmet gap and truly address patient needs”

Executive Director, Eisai

CNS Conferences – Product Team

Lydia Barlow

Brand Director

CONTACT US

Get in touch

We speak to hundreds of biopharmaceutical experts from industry and academia every day. We would love for you to be one of them. Contact us to discover how our events can accelerate your drug development.

Standard Form - CNS

"*" indicates required fields

Fill out the form below with your question and one of our team will get back to you.